< Back | |
25 May 2015 | |
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in Financial Express on May 22, 2015 titled "Some drugs made by Lupin, DRL & Mylan lose EU approval"<BR><BR>Dr Reddys Laboratories Ltd replied stating "The matter referred to in the news item was ongoing for a small part of our marketed portfolio in Europe. The overall impact on the Company's financials of this development is expected to be quite insignificant. Hence, we did not see a stock exchange notification necessary." | |
View all announcements for DR.REDDY'S LABORATORIES LTD. | Source: BSE India |